SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-161277
Filing Date
2022-05-27
Accepted
2022-05-26 19:08:41
Documents
14
Period of Report
2022-05-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340884d8k.htm   iXBRL 8-K 31808
2 EX-99.1 d340884dex991.htm EX-99.1 12112
  Complete submission text file 0001193125-22-161277.txt   217597

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hyac-20220526.xsd EX-101.SCH 4569
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hyac-20220526_def.xml EX-101.DEF 14410
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hyac-20220526_lab.xml EX-101.LAB 24430
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hyac-20220526_pre.xml EX-101.PRE 15437
8 EXTRACTED XBRL INSTANCE DOCUMENT d340884d8k_htm.xml XML 6129
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 22972105
SIC: 2833 Medicinal Chemicals & Botanical Products